RUBY

Rubius Therapeutics Inc.

1 day chart

About RUBY

Rubius Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing medicines called Red Cell Therapeutics (RCTs). Its RED PLATFORM is designed to genetically engineer, and culture Red Cell Therapeutics that are ready-to-use cellular therapies for the treatment of cancer and autoimmune diseases. It develops RCT product candidates based on therapeutic modalities such as immune system stimulation for the treatment of cancer and immune modulation to induce tolerance in autoimmune diseases. Its oncology program, RTX-240, is in the Phase I/II clinical trial for relapsed/refractory or solid tumors and in the Phase I clinical trial for relapsed/refractory acute myeloid leukemia (AML). Its RTX-321 is an allogeneic artificial antigen presenting cell (aAPC) product candidate, which is in the Phase I clinical trial for the treatment of advanced human papillomavirus (HPV) 16-positive cancers.

Buy US stocks in Australia starting with RUBY. Open an account and start investing today!

Market Capitalisation

$1.63M

Price-earnings ratio

Dividend yield

0.00%

Volume

1.97M

High today

$0.02

Low today

$0.02

Open price

$0.02

52-week high

$6.18

52-week low

$0.01

RUBY FAQs

How much is one share of Rubius Therapeutics Inc.?

One share of Rubius Therapeutics Inc. is valued at $0.02.

What is the ticker symbol for Rubius Therapeutics Inc.?

The ticker symbol for Rubius Therapeutics Inc. is RUBY.

How do I buy RUBY shares in Australia?

To buy RUBY stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in RUBY

What is the 52-week high for Rubius Therapeutics Inc. stock?

The Rubius Therapeutics Inc. 52-week high stock price is $6.18.

What is the 52-week low for Rubius Therapeutics Inc. stock?

The Rubius Therapeutics Inc. 52-week low stock price is $0.01.

What is the market capitalisation of Rubius Therapeutics Inc. RUBY?

As of 31/03/2023 Rubius Therapeutics Inc. has a market cap of $1.6M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.